Literature DB >> 14523472

Lack of asparagine depletion in the cerebrospinal fluid after one intravenous dose of PEG-asparaginase: a window study at initial diagnosis of childhood ALL.

I M Appel, J P V Pinheiro, M L den Boer, C Lanvers, N C M Reniers, J Boos, R Pieters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14523472     DOI： 10.1038/sj.leu.2403143

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

Review 1.  Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia.

Authors:  Xavier Thomas; Caroline Le Jeune
Journal:  Int J Hematol Oncol       Date:  2016-05-05

2.  Comment on "Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase".

Authors:  Wing H Tong
Journal:  Cancer Chemother Pharmacol       Date:  2021-09-01       Impact factor: 3.333

3.  Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemia.

Authors:  J C Panetta; A Gajjar; N Hijiya; L J Hak; C Cheng; W Liu; C H Pui; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2009-09-09       Impact factor: 6.875

4.  First-line treatment of acute lymphoblastic leukemia with pegasparaginase.

Authors:  Riccardo Masetti; Andrea Pession
Journal:  Biologics       Date:  2009-07-13

5.  Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase.

Authors:  John C Panetta; Yiwei Liu; Teodoro Bottiglieri; Erland Arning; Cheng Cheng; Seth E Karol; Jun J Yang; Yinmei Zhou; Hiroto Inaba; Ching-Hon Pui; Sima Jeha; Mary V Relling
Journal:  Cancer Chemother Pharmacol       Date:  2021-06-25       Impact factor: 3.288

Review 6.  Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.

Authors:  Vassilios I Avramis; Prakash Nidhi Tiwari
Journal:  Int J Nanomedicine       Date:  2006

7.  Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.

Authors:  Carmelo Rizzari; Claudia Lanvers-Kaminsky; Maria Grazia Valsecchi; Andrea Ballerini; Cristina Matteo; Joachim Gerss; Gudrun Wuerthwein; Daniela Silvestri; Antonella Colombini; Valentino Conter; Andrea Biondi; Martin Schrappe; Anja Moericke; Martin Zimmermann; Arend von Stackelberg; Christin Linderkamp; Michael C Frühwald; Sabine Legien; Andishe Attarbaschi; Bettina Reismüller; David Kasper; Petr Smisek; Jan Stary; Luciana Vinti; Elena Barisone; Rosanna Parasole; Concetta Micalizzi; Massimo Zucchetti; Joachim Boos
Journal:  Haematologica       Date:  2019-01-31       Impact factor: 9.941
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.